News from nuvation bio, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 12, 2021, 16:05 ET Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...

May 26, 2021, 07:00 ET Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...

May 17, 2021, 17:00 ET Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...

Mar 11, 2021, 17:15 ET Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...

Mar 11, 2021, 07:00 ET Nuvation Bio Granted Orphan Drug Designation for NUV-422 for the Treatment of Patients with Malignant Gliomas

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...

Jan 08, 2021, 07:00 ET Nuvation Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel...

Oct 26, 2020, 08:30 ET Nuvation Bio Expands Executive Team with Appointment of Healthcare Investment Banking Leader Jennifer Fox as Chief Financial Officer

Nuvation Bio Inc., a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that...

Oct 13, 2020, 08:30 ET Nuvation Bio Announces FDA Acceptance of Investigational New Drug (IND) Application for NUV-422 for Treatment of Patients with High-grade Gliomas

Nuvation Bio, Inc., an oncology company focused on revolutionizing cancer treatment by discovering, developing and delivering next-generation...

Oct 28, 2019, 08:00 ET Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds

Nuvation Bio, Inc., a stealth biotechnology company developing proprietary therapies focused on oncology, announces the closing of $275 million in an ...